Asymptomatic SARS-CoV-2 infection.

Eng Eong Ooi, Jenny G Low
Author Information
  1. Eng Eong Ooi: Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore; Department in Infectious Diseases, Singapore General Hospital, Singapore. Electronic address: engeong.ooi@duke-nus.edu.sg.
  2. Jenny G Low: Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore; Department in Infectious Diseases, Singapore General Hospital, Singapore.

Abstract

No abstract text available.

References

  1. Lancet Infect Dis. 2020 Sep;20(9):1051-1060 [PMID: 32539986]
  2. Lancet Infect Dis. 2020 Sep;20(9):1043-1050 [PMID: 32539988]
  3. N Engl J Med. 2020 May 28;382(22):2158-2160 [PMID: 32329972]
  4. Nat Rev Immunol. 2017 Feb;17(2):97-111 [PMID: 27748397]
  5. Nature. 2020 May;581(7809):465-469 [PMID: 32235945]
  6. Cell Host Microbe. 2020 Jun 10;27(6):879-882.e2 [PMID: 32359396]
  7. Euro Surveill. 2020 Mar;25(10): [PMID: 32183930]

MeSH Term

Betacoronavirus
COVID-19
Coronavirus Infections
Humans
Pandemics
Pneumonia, Viral
SARS-CoV-2
Seroconversion
Ships